<\/p>
The Medical Research Council (MRC) is one of the seven Research Councils sponsored by the Department for Business, Innovation and Skills (BIS). The MRC funds a broad portfolio of diabetes research which amounted to £24 million in 2012/13. Of this, £3.6 million (15%) is relevant to Type 1 Diabetes (T1D). This includes underpinning studies relevant to diabetes in general, as well as studies on the prevention, treatment and the downstream consequences of T1D. Expenditure on T1D research over the last five years is as follows:<\/p>
<\/p>
<\/p>
<\/p>
Medical Research Council expenditure on Type 1 diabetes, 2008/9 to 2012/13<\/p>
<\/p>
Year Expenditure<\/p>
<\/p>
2008/09 £4.7m<\/p>
<\/p>
2009/10 £3.7m<\/p>
<\/p>
2010/11 £3.6m<\/p>
<\/p>
2011/12 £4.0m<\/p>
<\/p>
2012/13 £3.6m<\/p>
<\/p>
<\/p>
<\/p>
Note: where a research project is related to both type 1 and type 2 diabetes, 100% of the project value has been included in the totals shown above.<\/p>
<\/p>
<\/p>
<\/p>
The MRC does not routinely analyse expenditure on diabetes research beyond an analysis of T1D and Type 2 Diabetes research. However, details of all research supported by the MRC, including summaries describing the aims of the research and links to research publications and outputs can be found on the Research Council UK's Gateway to Research at: http://gtr.rcuk.ac.uk/<\/a>.<\/p> <\/p> <\/p> <\/p> The MRC does not normally allocate funds to particular topics but always welcomes high quality applications into any aspect of human health. All applications are judged in open competition and the primary considerations in funding decisions are scientific quality and importance to human health. In keeping with the Haldane principle, decisions on research priorities and funding are taken by the Research Councils based on advice from the scientific community through peer review.<\/p> <\/p> <\/p> <\/p> The Technology Strategy Board spend on T1D in the last three years was £354,879.00. This relates to a project which ran in 2010/11.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/53", "label" : {"_value" : "Biography information for Lord Willetts"}
}
, "answeringMemberConstituency" : {"_value" : "Havant"}
, "answeringMemberPrinted" : {"_value" : "Mr David Willetts"}
, "dateOfAnswer" : {"_value" : "2014-06-09", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-06-09T15:56:31.2647243Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "26"}
, "answeringDeptShortName" : {"_value" : "Business, Innovation and Skills"}
, "answeringDeptSortName" : {"_value" : "Business, Innovation and Skills"}
, "date" : {"_value" : "2014-06-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Diabetes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Innovation and Skills, how much his Department has spent on research for a cure for Type 1 diabetes in the last three years; and if he will take steps to increase such funding in the forthcoming financial year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4068", "label" : {"_value" : "Biography information for Lord Harrington of Watford"}
}
, "tablingMemberConstituency" : {"_value" : "Watford"}
, "tablingMemberPrinted" : [{"_value" : "Richard Harrington"}
], "uin" : "198819"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}